115 studies found for:    fatty liver | Open Studies | United States
Show Display Options
Rank Status Study
1 Recruiting Genetic Studies of Non-Alcoholic Fatty Liver Disease
Conditions: Fatty Liver;   Liver Cirrhosis;   Non-Alcoholic Fatty Liver Disease;   Liver Transplantation;   Genetics
Intervention:
2 Recruiting EmricasaN, a Caspase inhibitOR, for Evaluation in Subjects With Non-Alcoholic Steatohepatitis (NASH) Fibrosis (ENCORE-NF)
Conditions: Non-alcoholic Steatohepatitis;   Fibrosis;   Liver Diseases
Interventions: Drug: Emricasan (5 mg);   Drug: Emricasan (50 mg);   Drug: Placebo
3 Recruiting Nonalcoholic Fatty Liver Disease (NAFLD) Adult Database 2
Condition: Liver Disease
Intervention:
4 Recruiting Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment
Condition: Non Alcoholic Steatohepatitis (NASH)
Interventions: Drug: Obeticholic Acid;   Drug: Placebo
5 Recruiting Combination OCA and Statins for Monitoring of Lipids (CONTROL)
Condition: Nonalcoholic Steatohepatitis
Interventions: Drug: Obeticholic Acid;   Drug: Atorvastatin;   Drug: Placebo
6 Recruiting NAFLD Pediatric Database 2
Condition: Liver Disease
Intervention:
7 Recruiting The Effect of Acetaminophen on Non-alcoholic Fatty Liver Disease Patients
Condition: Non-alcoholic Fatty Liver Disease (NAFLD)
Intervention: Drug: Acetaminophen
8 Recruiting The Effect Of NS-0200 Versus Placebo On Hepatic Fat Content In Patients With Non Alcoholic Fatty Liver Disease
Condition: NAFLD
Interventions: Drug: Sildenafil 0.5;   Drug: Sildenafil 1.0;   Drug: Metformin;   Drug: Leucine;   Drug: Placebo
9 Recruiting A Clinical Trial to Evaluate the Efficacy and Safety of Two Aramchol Doses Versus Placebo in Patients With NASH
Condition: Fatty Liver
Intervention: Drug: Aramchol
10 Recruiting Study of NGM282 in Patients With Nonalcoholic Steatohepatitis
Condition: Nonalcoholic Steatohepatitis
Interventions: Biological: NGM282;   Other: Placebo
11 Recruiting JKB-121 for the Treatment of Nonalcoholic Steatohepatitis
Condition: Nonalcoholic Steatohepatitis
Interventions: Drug: JKB-121: 5 mg twice daily;   Drug: JKB-121: 10 mg twice daily;   Drug: Placebo
12 Recruiting A Study of BMS-986036 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
Condition: Non-Alcoholic Steatohepatitis
Interventions: Drug: BMS-986036;   Drug: Placebo
13 Recruiting Open-Label Study To Evaluate Efficacy, Safety, Tolerability & PK of MN-001 on HDL & Triglyceride in NASH & NAFLD Subjects
Conditions: Non-alcoholic Steatohepatitis;   Hypertriglyceridemia;   Non-alcoholic Fatty Liver Disease
Intervention: Drug: MN-001
14 Recruiting A Phase ll Study of IMM-124E for Patients With Non-alcoholic Steatohepatitis
Condition: Non-alcoholic Steatohepatitis (NASH)
Interventions: Biological: IMM-124E;   Other: Placebo
15 Recruiting BREATHID Octanoate Breath Test With or Without Methacetin Breath Test for Correlation With Biopsy in NASH
Condition: Non-Alcoholic Steatohepatitis
Interventions: Device: Suspected NASH BreathID test with 13C-Octanoate;   Device: Suspected NASH Breath test with 13C Methacetin
16 Recruiting Tesamorelin Effects on Liver Fat and Histology in HIV
Conditions: Human Immunodeficiency Virus (HIV);   Nonalcoholic Fatty Liver Disease (NAFLD);   Nonalcoholic Steatohepatitis (NASH)
Interventions: Drug: tesamorelin;   Drug: Placebo
17 Recruiting A Phase II Study of the Effect of a Low Calorie Diet on Patients Undergoing Liver Resection
Conditions: Nonalcoholic Fatty Liver Disease;   Hepatic Steatosis;   Steatohepatitis
Intervention: Dietary Supplement: Optifast 800
18 Recruiting Dietary Treatment Study of Pediatric NAFLD
Condition: Nonalcoholic Fatty Liver Disease
Intervention: Other: Dietary modification
19 Recruiting Genetics of Fatty Liver Disease in Children
Condition: Non Alcoholic Fatty Liver Disease
Interventions: Other: ogtt;   Other: genotyping;   Other: abdominal and liver magnetic resonance imaging;   Other: stool sample;   Other: liver biopsy
20 Not yet recruiting Evaluating the Efficacy of CPAP Therapy for the Treatment of Fatty Liver
Condition: Non-alcoholic Fatty Liver Disease
Interventions: Device: CPAP;   Behavioral: LIfestyle

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years